Company / Operating Cash Flow per Share
BioLife Solutions, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.41
FY2025
5-year range
-$0.29 / $0.41
FY2021-FY2025
Trend
+125.9%
vs FY2024
Sector context
#123 of 155
Health Care
What the data says
BioLife Solutions, Inc.'s operating cash flow per share of $0.41 is lower than 79% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-0.35 in FY2016 to $0.41 in FY2025.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of +11.2%.
Improved from $-0.29 to $0.41 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
-93.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 125.9% year-over-year.
- Ranks #123 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +125.9% |
| FY2024 | $0.18 | +164.0% |
| FY2023 | -$0.29 | -45.1% |
| FY2022 | -$0.20 | -65.2% |
| FY2021 | -$0.12 | -149.0% |
| FY2020 | $0.24 | +290.4% |
| FY2019 | $0.06 | +132.8% |
| FY2018 | $0.03 | -43.1% |
| FY2017 | $0.05 | +113.5% |
| FY2016 | -$0.35 | +15.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026